Clinical Pathology

We offer clinical pathology testing services for non-clinical drug evaluation and clinical trials, and can develop new assay methods and conduct methodological validation according to customer requirements.

Clinical Pathology

Blood test

White blood cell count (WBC), basophil differential white blood cell count (Baso), neutrophil differential count (Neut), lymphocyte differential count (Lymph), monocyte differential count (Mono), eosinophil differential count (Eos), red blood cell count (RBC), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin content (MCH), mean corpuscular hemoglobin concentration (MCHC), platelet count (PLT), hemoglobin level (HGB), platelet distribution width (PDW), mean platelet volume (MPV), absolute reticulocyte count (Retic), and reticulocyte percentage (Retic%).

 

Blood coagulation test

Exogenous coagulation factor activity assays (factors II, V, VII, and X), endogenous coagulation factor activity assays (factors VIII, IX, XI, and XII), prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB), thrombin time (TT), platelet function-related tests (platelet aggregation rate), anticoagulation-related tests (AT-III, α2-antiplasmin, plasminogen), fibrinolytic system-related tests (D-D dimer), and lupus anticoagulant assays (LA1, LA2), among others.

 

Serum biochemical test

Serum protein metabolism functions (TP, ALB), glucose metabolism-related tests (GLU, β-hydroxybutyrate), ion measurements (ISE, Ca, P), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK), gamma-glutamyl transferase (GGT), lactate dehydrogenase (LDH), calcium (Ca), sodium (Na+), potassium (K+), chloride (Cl-), total cholesterol (CHOL), creatinine (CREA), uric acid (UA), urea (UREA), total protein (TP), lipid metabolism (TCHOL, TG, HDL-C, LDL-C), direct bilirubin (DBIL), total bilirubin (TBIL), total bile acids (TBA), glucose (GLU), inorganic phosphorus (P), immunoglobulin and complement tests (IGA, IGG, IGM, C3, C4), acute-phase reactants (CRP, serum amyloid A protein), pancreatic function-related markers (AMY, LIP), and others.

 

Chemiluminescence detection

Cardiac injury markers (CTNI, CK-MB, MYO), heart failure markers (BNP), reproductive hormones (FSH, LH, P, E2, PRL, T), thyroid function tests (T3, T4, FT3, FT4, TSH), inflammation-related markers (IL-6), erythropoietin (EPO), tumor markers (AFP, CEA, PSA, cancer antigen 125, etc.).

 

Urine test

Urine physical examination, urine dry chemistry analysis, glucose (GLU), pH, ketones (KET), nitrite (nitrite), bilirubin (BIL), protein (PRO), occult blood (BLO), urobilinogen (URO), specific gravity (SG), and white blood cells (WBC), among others.

 

Flow cytometry

T-cell subtype profiling and enumeration, B-cell subtype profiling and enumeration, NK cell activity assay, DC cell subtyping, cell cycle analysis, and cell proliferation detection, etc.

 

Immune assay

Urine physical examination, urine dry chemistry testing, and other markers related to kidney injury (KIM-1), as well as immune function-related indicators (IgE, IgG, IgM, TDAR, circulating immune complexes CIC).

 

Morphological detection

Morphology of bone marrow in experimental animals, morphology of blood cells, morphology of formed elements in urine, and morphology of cerebrospinal fluid/ joint fluid/serous cavity effusions, etc.